HomeADAP • NASDAQ
add
Adaptimmune Therapeutics PLC - ADR
$0.66
Makalipas ang Oras ng Trabaho:(0.24%)-0.0016
$0.66
Sarado: Nob 22, 6:37:41 PM GMT-5 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$0.64
Sakop ng araw
$0.60 - $0.66
Sakop ng taon
$0.42 - $2.05
Market cap
168.30M USD
Average na Volume
1.96M
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
TheStreet
28 minuto ang nakalipas
Goldman Sachs analyst sees starting point for year-end S&P 500 rally
0.35%
1.12%
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 40.90M | 458.83% |
Gastos sa pagpapatakbo | 55.58M | 3.02% |
Net na kita | -17.62M | 61.37% |
Net profit margin | -43.07 | 93.09% |
Kita sa bawat share | -0.01 | 70.15% |
EBITDA | -11.86M | 72.88% |
Aktuwal na % ng binabayarang buwis | -4.95% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 186.09M | 15.06% |
Kabuuang asset | 317.44M | 7.01% |
Kabuuang sagutin | 237.45M | 13.88% |
Kabuuang equity | 79.99M | — |
Natitirang share | 255.88M | — |
Presyo para makapag-book | 2.05 | — |
Return on assets | -11.48% | — |
Return on capital | -24.62% | — |
Cash Flow
Net change in cash
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -17.62M | 61.37% |
Cash mula sa mga operasyon | -54.45M | -20.58% |
Cash mula sa pag-invest | -66.02M | -215.20% |
Cash mula sa financing | 25.00M | 4,094.80% |
Net change in cash | -95.25M | -840.01% |
Malayang cash flow | -44.13M | -74.80% |
Tungkol
Itinatag
2008
Website
Mga Empleyado
449
